Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |